FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

33 results

apixaban
(Apixaban)
Macleods Pharmaceuticals Limited
Usage: Apixaban is indicated for reducing stroke and systemic embolism risk in nonvalvular atrial fibrillation, prophylaxis of deep vein thrombosis following hip or knee surgery, and treatment of deep vein thrombosis and pulmonary embolism. It also reduces the risk of recurrent DVT and pulmonary embolism after initial therapy.
corvert
(ibutilide fumarate)
Pharmacia & Upjohn Company LLC
Usage: CORVERT Injection is indicated for the rapid conversion of recent-onset atrial fibrillation or atrial flutter to sinus rhythm. It is less effective in patients with arrhythmias lasting longer than 90 days, as its effectiveness in such cases has not been established.
dabigatran etexilate
(dabigatran etexilate)
Apotex Corp.
Usage: Dabigatran etexilate capsules are indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, preventing their recurrence, and prophylaxis following hip replacement surgery in adult patients.
dabigatran etexilate
(Dabigatran Etexilate)
Mylan Pharmaceuticals Inc.
Usage: Dabigatran etexilate capsules are indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating and preventing deep vein thrombosis and pulmonary embolism in adults and pediatric patients aged 8-17, and preventing recurrence of venous thromboembolic events.
dabigatran etexilate
(Dabigatran etexilate)
Dr. Reddy's Laboratories Inc.
Usage: Dabigatran etexilate capsules are indicated for reducing stroke risk in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, providing prophylaxis following hip replacement surgery, and treating and preventing venous thromboembolic events in pediatric patients aged 8 to under 18 years.
diltiazem hydrochloride
(diltiazem hydrochloride)
Eugia US LLC
Usage: Diltiazem hydrochloride injection is indicated for the temporary control of rapid ventricular rate in atrial fibrillation or flutter, and for the rapid conversion of paroxysmal supraventricular tachycardia to sinus rhythm. Continuous ECG monitoring is required, particularly during intravenous infusion.
dofetilide
(Dofetilide)
VGYAAN Pharmaceuticals LLC
Usage: Dofetilide Capsules are indicated for maintaining normal sinus rhythm and delaying recurrence of atrial fibrillation/atrial flutter in symptomatic patients who have been converted to sinus rhythm. They are also used for converting atrial fibrillation/flutter to normal sinus rhythm but are ineffective in paroxysmal cases.
dofetilide
(DOFETILIDE)
NorthStar RxLLC
Usage: Dofetilide capsules are indicated for maintaining normal sinus rhythm in patients with atrial fibrillation/atrial flutter (AF/AFl) post-conversion and for converting AF/AFl to normal sinus rhythm. It is intended for symptomatic patients and is not effective for paroxysmal AF.
dofetilide
(Dofetilide)
EXELAN PHARMACEUTICALS, INC.
Usage: Dofetilide capsules are indicated for maintaining normal sinus rhythm and delaying the recurrence of atrial fibrillation/atrial flutter in symptomatic patients after conversion. They are also used for converting atrial fibrillation/flutter to normal sinus rhythm, though not effective for paroxysmal atrial fibrillation.
flecainide acetate
(Flecainide Acetate)
Amneal Pharmaceuticals LLC
Usage: Flecainide is indicated for preventing paroxysmal supraventricular tachycardias (PSVT) and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. It is also used for documented life-threatening ventricular arrhythmias. Its use is contraindicated in patients with recent myocardial infarction and chronic atrial fibrillation is not recommended.

Medications for Atrial Fibrillation

apixaban

corvert

dabigatran etexilate

dabigatran etexilate

dabigatran etexilate

diltiazem hydrochloride

dofetilide

dofetilide

dofetilide

flecainide acetate